—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company’s double-stranded RNA ligases compared to wild-type enzymes— —Management to host conference call today at 4:30 pm EST to discuss data— REDWOOD CITY, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced data from three pr ...

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the Company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $50 million. “Alector is in a strong cash position with more than $457 million in cash and investments. This credit facility further enhances our financial strength and provides the Company with increased strategic and oper ...

DURANGO, Colo., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), an international franchisor and producer of premium chocolates and other confectionery products, including gourmet caramel apples, today announced the opening of two new stores and one kiosk location across three U.S. markets. RMCF is pleased to highlight the success and commitment of its franchisees, who are bringing the Rocky Mountain Chocolate Factory experience to Chic ...

Completes the Company's strategic move away from capital equipment businessesBOTHELL, Wash., Nov. 14, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the sale of its final wholly owned freezer subsidiary, Arctic Solutions, Inc. ("Custom Biogenic Systems" or "CBS"), for $6.1 million in cash."We have now completed the divestiture of all our freeze ...

SAN FRANCISCO, Nov. 14, 2024 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its third quarter fiscal 2025 results will be released on Thursday, December 5, 2024, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically a ...

The addition of advanced liquid cooling technology addresses increased heat requirements across the full spectrum of AI workloads and high-performance computingAUSTIN, Texas, Nov. 14, 2024 /PRNewswire/ -- Flex (NASDAQ: FLEX) announced today it has acquired JetCool Technologies, a leading liquid cooling company for data centers. The acquisition bolsters Flex's data center and power portfolio to help hyperscale and enterprise customers solve growing power, heat, and scale challenges in the era of AI. Building ...

New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences  Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response against HPV-6 and HPV-11 and drive recruitment of T cells into airway tissues and papilloma Data showed INO-3107 induced expansion of new clonal T cells that infiltrate airway tissues and correspond with reduction of surgeries for RRP patients observed in Phase 1/2 trial Continued progress on preparing reg ...

Highlights successful Evie Ring back-in-stock executionUpdates status of EvieMED 510(k) application reviewFocuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET TodayPLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct- ...

NRX-100 (IV Ketamine) safety and efficacy data have been aggregated from clinical trials in more than 500 patients in collaboration with leading US and French Universities that demonstrate a highly significant reduction in suicidal ideation compared to placebo and active comparator. IV ketamine has been shown to be superior (in post-hoc analysis) to electroshock therapy in treating depression. Stability data has now been generated for three manufacturing lots required for NDA filing in suicidal depressio ...

Reports 60% Increase in ARR to $17.6 Million, Positive Net Income and Cash Flow, Adjusted EBITDA of $1.3 MillionHENDERSON, Nev., Nov. 14, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal first quarter ended September 30, 2024.Fiscal First Quarter 2025 Summary Research Solutions, Inc. Logo (PRNewsfoto/Research Solutions, Inc.) Total revenue of $12.0 million, a 20% increase from the prior-year quar ...